S-MTC

• Description :

  S-MTC is a selective type I nitric oxide synthase (NOS) inhibitor.

• Product Name Alternative :

  S-Methyl-L-thiocitrulline

• UNSPSC :

  12352211

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  NO Synthase

• Type :

  Reference compound

• Related Pathways :

  Immunology/Inflammation

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/S-MTC.html

• Solubility :

  10 mM in DMSO

• Smiles :

  N[C@@H](CCCNC(SC)=N)C(O)=O

• Molecular Formula :

  C7H15N3O2S

• Molecular Weight :

  205.28

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Law A, et al. Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity. Br J Pharmacol. 2001 Aug;133 (7) :1114-24.|[2]Zelinski LM, et al. A prolonged nitric oxide-dependent, opioid-mediated antinociceptive effect of hyperbaric oxygenin mice. J Pain. 2009 Feb;10 (2) :167-72.|[3]Wakefield ID, et al. Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-L-thiocitrulline and L-NAME, in conscious rats. Br J Pharmacol. 2003 Jul;139 (6) :1235-43.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [156719-41-4]